BDBM102344 US10562854, No. A18::US8536181, A18::US9278930, A18

SMILES OCc1ccccc1Cn1ccc(CN2CCCCCC2)c(O)c1=O

InChI Key InChIKey=SEDQAFVMDOBVEF-UHFFFAOYSA-N

Data  8 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 102344   

TargetEgl nine homolog 1(Homo sapiens (Human))
Aerpio Therapeutics

US Patent
LigandPNGBDBM102344(US10562854, No. A18 | US8536181, A18 | US9278930, ...)
Affinity DataIC50:  1.80E+4nMAssay Description:EGLN enzyme activity assay is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALDI-TOF MS.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVascular endothelial growth factor A(Homo sapiens (Human))
Aerpio Therapeutics

US Patent
LigandPNGBDBM102344(US10562854, No. A18 | US8536181, A18 | US9278930, ...)
Affinity DataIC50:  2.92E+4nMAssay Description:ELISA assay using VEGF.More data for this Ligand-Target Pair
In DepthDetails US Patent